vs

Side-by-side financial comparison of Immunovant, Inc. (IMVT) and WESTPORT FUEL SYSTEMS INC. (WPRT). Click either name above to swap in a different company.

WESTPORT FUEL SYSTEMS INC. is the larger business by last-quarter revenue ($12.5M vs $8.4M, roughly 1.5× Immunovant, Inc.). WESTPORT FUEL SYSTEMS INC. runs the higher net margin — -274.8% vs -899.0%, a 624.2% gap on every dollar of revenue. On growth, Immunovant, Inc. posted the faster year-over-year revenue change (140.7% vs -11.4%). WESTPORT FUEL SYSTEMS INC. produced more free cash flow last quarter ($-6.4M vs $-59.8M).

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative monoclonal antibody therapies for patients with serious, rare autoimmune and inflammatory diseases. Its lead product candidate covers multiple autoimmune indications, with core U.S. operations and a global market expansion strategy.

Westport Innovations is a company that develops alternative fuel, low-emissions technologies to allow engines to operate on clean-burning fuels such as compressed natural gas (CNG), liquefied natural gas (LNG), hydrogen and biofuels such as landfill gas. Headquartered in Vancouver, British Columbia, Canada, where the company was founded, Westport also has facilities in France, Sweden, Italy, China, Australia and the United States.

IMVT vs WPRT — Head-to-Head

Bigger by revenue
WPRT
WPRT
1.5× larger
WPRT
$12.5M
$8.4M
IMVT
Growing faster (revenue YoY)
IMVT
IMVT
+152.2% gap
IMVT
140.7%
-11.4%
WPRT
Higher net margin
WPRT
WPRT
624.2% more per $
WPRT
-274.8%
-899.0%
IMVT
More free cash flow
WPRT
WPRT
$53.4M more FCF
WPRT
$-6.4M
$-59.8M
IMVT

Income Statement — Q4 FY2024 vs Q2 FY2025

Metric
IMVT
IMVT
WPRT
WPRT
Revenue
$8.4M
$12.5M
Net Profit
$-75.3M
$-34.3M
Gross Margin
6.7%
Operating Margin
-896.2%
-8.1%
Net Margin
-899.0%
-274.8%
Revenue YoY
140.7%
-11.4%
Net Profit YoY
-26.7%
-690.4%
EPS (diluted)
$-0.50
$-1.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMVT
IMVT
WPRT
WPRT
Q2 25
$12.5M
Q3 24
$4.9M
Q2 24
$14.1M
Q1 24
$8.4M
Q4 23
$8.9M
Q3 23
$3.6M
Q2 23
$4.1M
Q1 23
$3.5M
Net Profit
IMVT
IMVT
WPRT
WPRT
Q2 25
$-34.3M
Q3 24
$-3.9M
Q2 24
$5.8M
Q1 24
$-75.3M
Q4 23
$-51.4M
Q3 23
$-58.7M
Q2 23
$-73.9M
Q1 23
$-59.4M
Gross Margin
IMVT
IMVT
WPRT
WPRT
Q2 25
6.7%
Q3 24
13.6%
Q2 24
16.7%
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23
Operating Margin
IMVT
IMVT
WPRT
WPRT
Q2 25
-8.1%
Q3 24
-43.9%
Q2 24
-54.9%
Q1 24
-896.2%
Q4 23
-576.8%
Q3 23
-1629.6%
Q2 23
-1819.1%
Q1 23
-1736.3%
Net Margin
IMVT
IMVT
WPRT
WPRT
Q2 25
-274.8%
Q3 24
-79.3%
Q2 24
41.2%
Q1 24
-899.0%
Q4 23
-575.6%
Q3 23
-1642.3%
Q2 23
-1818.9%
Q1 23
-1707.8%
EPS (diluted)
IMVT
IMVT
WPRT
WPRT
Q2 25
$-1.98
Q3 24
$-0.22
Q2 24
$0.34
Q1 24
$-0.50
Q4 23
$-0.36
Q3 23
$-0.45
Q2 23
$-0.57
Q1 23
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMVT
IMVT
WPRT
WPRT
Cash + ST InvestmentsLiquidity on hand
$635.4M
$6.1M
Total DebtLower is stronger
$977.0K
Stockholders' EquityBook value
$617.8M
$108.9M
Total Assets
$666.4M
$272.1M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMVT
IMVT
WPRT
WPRT
Q2 25
$6.1M
Q3 24
Q2 24
Q1 24
$635.4M
Q4 23
$690.9M
Q3 23
$269.9M
Q2 23
$330.0M
Q1 23
$376.5M
Total Debt
IMVT
IMVT
WPRT
WPRT
Q2 25
$977.0K
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23
Stockholders' Equity
IMVT
IMVT
WPRT
WPRT
Q2 25
$108.9M
Q3 24
$149.3M
Q2 24
$151.5M
Q1 24
$617.8M
Q4 23
$679.3M
Q3 23
$251.8M
Q2 23
$299.9M
Q1 23
$362.5M
Total Assets
IMVT
IMVT
WPRT
WPRT
Q2 25
$272.1M
Q3 24
Q2 24
Q1 24
$666.4M
Q4 23
$711.4M
Q3 23
$292.1M
Q2 23
$351.2M
Q1 23
$405.8M
Debt / Equity
IMVT
IMVT
WPRT
WPRT
Q2 25
0.01×
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMVT
IMVT
WPRT
WPRT
Operating Cash FlowLast quarter
$-59.7M
$-5.6M
Free Cash FlowOCF − Capex
$-59.8M
$-6.4M
FCF MarginFCF / Revenue
-714.4%
-51.6%
Capex IntensityCapex / Revenue
1.8%
6.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-214.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMVT
IMVT
WPRT
WPRT
Q2 25
$-5.6M
Q3 24
$-11.7M
Q2 24
$1.5M
Q1 24
$-59.7M
Q4 23
$-47.1M
Q3 23
$-60.1M
Q2 23
$-47.4M
Q1 23
$-55.8M
Free Cash Flow
IMVT
IMVT
WPRT
WPRT
Q2 25
$-6.4M
Q3 24
$-11.9M
Q2 24
$262.0K
Q1 24
$-59.8M
Q4 23
$-47.2M
Q3 23
$-60.1M
Q2 23
$-47.4M
Q1 23
$-55.8M
FCF Margin
IMVT
IMVT
WPRT
WPRT
Q2 25
-51.6%
Q3 24
-243.4%
Q2 24
1.9%
Q1 24
-714.4%
Q4 23
-528.7%
Q3 23
-1682.4%
Q2 23
-1166.4%
Q1 23
-1604.0%
Capex Intensity
IMVT
IMVT
WPRT
WPRT
Q2 25
6.6%
Q3 24
3.8%
Q2 24
8.9%
Q1 24
1.8%
Q4 23
1.5%
Q3 23
1.0%
Q2 23
1.1%
Q1 23
0.7%
Cash Conversion
IMVT
IMVT
WPRT
WPRT
Q2 25
Q3 24
Q2 24
0.26×
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons